Functional and Clinical Evidence That TAZ is a Candidate Oncogene in Hepatocellular Carcinoma

E-ISSN： 1097-4644|116|11|2465-2475

ISSN： 0730-2312

Source： JOURNAL OF CELLULAR BIOCHEMISTRY, Vol.116, Iss.11, 2015-11, pp. : 2465-2475

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ZNF667 Serves as a Putative Oncogene in Human Hepatocellular Carcinoma

Cellular Physiology and Biochemistry, Vol. 41, Iss. 6, 2017-05 ,pp. : 2523-2533

Karger

Access to resources Recommend Favorite

Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice

JOURNAL OF MEDICAL VIROLOGY, Vol. 87, Iss. 8, 2015-08 ,pp. : 1368-1376

John Wiley & Sons Inc

Access to resources Recommend Favorite

Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma

By Lee Joycelyn J. X. Chan Jack J. Choo Su Pin

Diseases, Vol. 3, Iss. 4, 2015-10 ,pp. : 306-324

MDPI

Access to resources Recommend Favorite

LC‐MS/MS‐based serum proteomics for identification of candidate biomarkers for hepatocellular carcinoma

PROTEOMICS, Vol. 15, Iss. 13, 2015-07 ,pp. : 2369-2381

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of Serum Chemerin Levels on Liver Functional Reserves and Platelet Counts in Patients with Hepatocellular Carcinoma

By Imai Kenji Takai Koji Hanai Tatsunori Shiraki Makoto Suzuki Yusuke Hayashi Hideki Naiki Takafumi Nishigaki Youichi Tomita Eiichi Shimizu Masahito Moriwaki Hisataka

International Journal of Molecular Sciences, Vol. 15, Iss. 7, 2014-06 ,pp. : 11294-11306

MDPI

Access to resources Recommend Favorite